Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
92.21
+0.91 (+1.00%)
Streaming Delayed Price
Updated: 10:23 AM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
3 AI Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
These pick-and-shovel AI plays are poised to deliver tremendous returns with rapid sales expansion over the coming years.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
September 01, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus to Present at the Wells Fargo Healthcare Conference
August 31, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty
August 03, 2023
Agreement enhances Lantheus’ strong liquidity position and supports continued pipeline advancement and commercial readiness
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Analyst Ratings for Lantheus Holdings
June 01, 2023
Via
Benzinga
Lantheus Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time
July 20, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Neogen Stock Shows Market Leadership With Jump To 86 RS Rating
June 21, 2023
On Wednesday, Neogen stock had its Relative Strength (RS) Rating upgraded to 86, up from 80 a day earlier.
Via
Investor's Business Daily
Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
June 12, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Holdings's Return On Capital Employed Overview
May 15, 2023
Via
Benzinga
Lantheus Holdings Earnings Perspective: Return On Capital Employed
February 27, 2023
Via
Benzinga
Why Shares of Lantheus Holdings Rose This Week
February 25, 2023
The company's fourth-quarter and full-year earnings were a pleasant surprise.
Via
The Motley Fool
2 Medical Imaging Stocks That Are Better Buys Than Nano-X
June 03, 2023
Both companies are using artificial intelligence to improve their products.
Via
The Motley Fool
Lantheus to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
May 23, 2023
PYLARIFY success leads to maximum payment in first year
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
7 Stocks That Wall Street Analysts Are Loving in May
May 21, 2023
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.
Via
InvestorPlace
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday
May 04, 2023
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 04, 2023
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.
Via
Benzinga
Why Shares of Lantheus Holdings Are Up Thursday
May 04, 2023
The company reported a record quarter for revenue.
Via
The Motley Fool
Lantheus Reports First Quarter 2023 Financial Results
May 04, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
April 24, 2023
From
Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via
GlobeNewswire
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
April 20, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Announces Two Key Executive Promotions
March 17, 2023
Paul Blanchfield promoted to President; Dan Niedzwiecki promoted to Chief Administrative Officer
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Are These Medical Device Makers Getting Ready To Rally?
March 10, 2023
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors.
Via
MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
March 08, 2023
Via
Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 23, 2023
Gainers
Via
Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
February 23, 2023
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4
February 23, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.35% to 33,162.00 while the NASDAQ rose 0.91%...
Via
Benzinga
Lantheus Shares Jump On Upbeat 2023 Guidance, Q4 Earnings Surpass Expectations
February 23, 2023
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.